DIRUI(SZ:300396) Sou Hu Cai Jing·2025-03-31 09:54Group 1 - The core viewpoint of the article highlights the decline in the stock price of Dirui Medical, which closed at 14.6 yuan, down 7.42%, with a rolling PE ratio of 28.05 times and a total market value of 3.981 billion yuan [1] - The average PE ratio for the medical device industry is 44.72 times, with a median of 32.59 times, placing Dirui Medical at the 66th position in the industry ranking [1] - As of February 28, 2025, the number of shareholders in Dirui Medical decreased by 1,477 to 18,086, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - Dirui Medical specializes in the research, development, production, marketing, and service of medical testing instruments and related reagents, with major products including urine analysis, biochemical analysis, chemiluminescence immunoassay, gynecological secretion analysis, blood cell analysis, coagulation analysis, and integrated laboratory series [1] - The company holds 213 patents, including 136 invention patents and 96 software copyrights [1] - In the latest financial report for 2024, Dirui Medical reported operating revenue of 1.218 billion yuan, a year-on-year decrease of 11.63%, and a net profit of 142 million yuan, down 48.50%, with a gross profit margin of 43.84% [1]